I – JOB SUMMARY
Reporting to the Head of Real-World Evidence (RWE), the Head of Behavioral Science will be responsible for the coordination and development of the behavioral science evidence generation strategy within the overall CHC RWE strategy. The Head of Behavioral Science will work closely with the Head of RWE and RWE Engagement Leads to ensure that a strong behavioral science strategy is incorporated into the overall RWE strategy for all priority areas across Sanofi Consumer Healthcare (CHC), as well as work with other cross-functional leaders to drive "consumer science" across the organization.
The Head of Behavioral Science will also be responsible for leading external engagements with regulatory and health authorities around the adoption and utilization of COA’s and other behavioral science methodologies for labelling and consumer claims. In this regard, he/she will ensure that the CHC behavioral evidence generations strategy is not only aligned with regulatory and health authority views, but also driving the adoption of behavioral evidence uniquely positioned for CHC. He/she will also serve as internal expert for overall behavior science strategy, as well as for behavioral science evidence generation activities.
II – KNOWLEDGE, SKILL, FORMAL EDUCATION & EXPERIENCE REQUIREMENTS
Knowledge and Skills
Deep understanding of interpretation of behavioral outcomes and their applicability in regulatory and health authority current context, as well as increasing the adoption/utilization of the patient voice in future evidence generation activities
Experience in a wide variety of behavioral science methodologies and an understanding of the applicability and context of each study’s inherent strengths and weaknesses
Entrepreneurial mindset to drive the development of RWE organization
Ability to translate behavioral science concepts to cross-functional senior leadership and demonstrate business value/impact of results
Experience with developing and presenting regulatory and health authority materials related to behavioral science evidence
Oversight & Coordination
Ability to work closely with RWE Engagement Leads to develop and align behavioral health strategy with RWE strategy for each priority category/region
Collaborate with other internal functions to maximize value of evidence including those in other areas of CHC Science organization, other areas of CHC in general including Growth Hub, or other parts of Sanofi including Patient Insights organization
Foster external partnerships with behavioral science subject matter experts and key opinion leaders to leverage for additional external expertise in key areas
Partner with external vendors to further adopt innovative methodologies to incorporate into evidence generation strategies
Ability to work autonomously in a team environment, communicate effectively, and act as internal expert for behavioral science related topics
Communication
Strong presentation skills, including ability to present at senior-level internal meetings, as well as key external meetings including scientific congresses, as well as regulatory and health authority engagements
Strong communication skills with the ability to distil complexity down to what matters to stakeholders.
Excellent written and verbal communication skills
Strong English skills (verbal and written if English is the second language) i.e., ability to exchange fluently (incl. negotiation), lead international meetings, write meeting minutes/ emails/ study documents / internal & external communication
Able to communicate effectively to senior and executive leadership
Ability to adapt his/her communication, address the right topics and adapt content/level of details to the right recipients
Encourage collaboration and communication within and beyond the team, contribute to building a positive team spirit
Decision-making and problem Solving
Able to respond quickly and effectively when faced with decisions
Creative thinker when faced with novel problems
Solution oriented
Able to anticipate and handle issues properly and with autonomy
Collaboration with partners
Ability to work cross functionally across domains including translating outcomes for commercial/business value, working with scientific colleagues on regulatory and health authority interactions
Able to foster and develop internal and external relationships to further drive behavioral science in CHC
Respond constructively to requests (i.e. either accept or challenge the request, why, when, who & what)
Share expertise through external communications, working groups, and foster internal RWE knowledge among senior leaders
Act for change
Ability to learn from experience and able to deal well with the changed circumstances in the environment (be open to new ideas and changes to be successful)
Readily adapt to new environment, jobs, technologies and processes
Ability to deal with frequent changes, delays or unexpected events
III – Formal Education and Experience Required
Advanced scientific degree (i.e. MD, PhD, MPH, MSc) with related experience in relevant behavioral science field
Expertise in relevant scientific methodologies concerning behavioral studies, including patient journey studies, consumer preference studies, multi-criteria decision analysis studies, etc.
At least 10 years of experience in Behavior and Implementation Science, including global strategic experience
Clinical experience, skills and judgement are valued
Experience in CHC is highly desirable
IV – PRINCIPAL DUTIES AND RESPONSIBILITIES
Develop and lead the CHC behavioral science evidence generation strategy
Lead the overall CHC behavioral science evidence generation strategy and ensure alignment with the overall and individual RWE strategies, as well as current regulatory and health authority contexts
Lead key behavioral science evidence generation activities and advise and support additional cross-functional activities
Drive innovation in CHC behavioral science
Pursue and develop external partnerships with vendors with innovative capabilities/methodologies to unlock new research questions around consumer journeys
Pursue and develop external partnerships with subject matter experts and key opinion leaders to further establish expertise in priority countries/areas
Drive behavioral science business value translation
Translate behavioral science evidence into business value for internal senior and executive leaders
Demonstrate value of innovation and adoption of behavior science for consumer claims
Cambridge, MA
As the specialty care global business unit of Sanofi, we are focused on rare diseases, rare blood disorders, multiple sclerosis, oncology and immunology. More than 30 years since we began, we remain just as committed to and passionate about advancing therapies that offer hope to patients and families.
Our approach is shaped by a long history of developing highly specialized treatments and forging close relationships with physician and patient communities. Founded as Genzyme in Boston in 1981, we rapidly grew to become one of the world’s leading biotechnology companies, recognized for our pioneering development of treatments for rare genetic disorders and our innovative contributions to medical science and biomanufacturing.
Genzyme became part of Sanofi in 2011. While continuing to focus on rare diseases, we also established ourselves as a leader in the field of multiple sclerosis. In 2016, our focus expanded to include Sanofi’s programs in oncology and immunology. In 2018, with the acquisitions of Bioverativ and Ablynx, we further expanded our focus to include rare blood disorders, bringing deep expertise in hematology.
Our ambition is to be the industry leader in specialty care. We currently provide more than 25 treatments to patients globally, with many potential new therapies being studied in clinical trials and in Sanofi laboratories.
Driven by our commitment to patients, we strive to develop strong relationships with our patient communities, listening to their perspectives so that we can truly understand their needs. These collaborations continue to guide and motivate us as we work to push the boundaries of medicine and technology to develop new and better therapies where none existed before.